GlassScriptPhysician profile
Mohammad Z Hoque
NPI 1124048913
$4,194.87
in general payments reported to CMS, 2019-2025
16 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,224 · 2020: $488 · 2021: $210 · 2022: $386 · 2023: $279 · 2024: $245 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baylis Medical Company INC | $1,082.28 | 2019 | |
| Cardiovascular Systems INC. | $1,038.42 | 2019-2023 | Diamondback Coronary |
| Edwards Lifesciences Corporation | $591.74 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $403.86 | 2021-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Medtronic, INC. | $380.92 | 2021-2025 | Symplicity G3, Ffrangio, Corevalve Evolut R |
| Medicure Pharma INC. | $110.51 | 2019 | |
| Penumbra, INC. | $107.46 | 2023-2024 | Indigo System |
| Abiomed | $104.01 | 2021 | |
| Biosense Webster, INC. | $97.55 | 2022 | |
| Ethicon US, LLC | $96.37 | 2024-2025 | Certus 140 |
| Abbott Laboratories | $63.77 | 2021-2025 | Aveir, Assurity |
| Terumo Medical Corporation | $36.81 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.33 | 2019-2020 | |
| Pfizer INC. | $20.64 | 2025 | |
| Philips North America LLC | $19.34 | 2025 | Azurion 7 M20 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hoque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.